Macrogenics (MGNX) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 31, 2026

Net selling: insiders sold $129K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: -$129K netNet selling
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 1 added, 0 cutMore adding
Federal contractsUSAspending.gov, last 12 months: 1 awardAwards on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about MGNX filings

Are insiders buying or selling MacroGenics Inc (MGNX) stock?

Net selling: insiders sold $129K and bought $0 of MGNX stock on the open market in the 90 days to Oct 31, 2026, according to SEC Form 4 filings. $129K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Peters, Jeffrey Stuart (Senior VP, GC, and Secretary), who sold $129K. The latest filing was on Aug 20, 2026.

Which members of Congress have traded MGNX recently?

None. No member of Congress disclosed a MGNX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MGNX smart-money data?

This summary uses filings available on Oct 31, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on MGNX

Lean long1 source:
- Funds
Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Jeffrey Stuart Peters, sold $129K, scheduled plan sale, filed Aug 20
Lean short · thin1 sale · $129K
1 of 1 on scheduled plans. Form 4 filings.
Politicians
No recent politician filings found
Funds
- BlackRock, added +$18.3M, holdings at Jun 30
Lean long · thin1 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about MGNX filings

Are insiders buying or selling MacroGenics Inc (MGNX) stock?

Which members of Congress have traded MGNX recently?

None. No member of Congress disclosed a MGNX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MGNX smart-money data?

Funds

What funds are doing

1 move · 6 mo

Buys/Adds$18.3M

Buys/Adds (1)

BR
BlackRock
Q2 2026 13F
$18.3M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 13, 2026

Earnings came in $0.88 a share above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 13, 2026

Period ending

Jun 30, 2026

Earnings per share

$1.14+$0.88 beat

$0.26 expected

Revenue

$32.8M

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Nov 11, 2026, in 11 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 13, 2026	$1.14est. $0.26	+$0.88beat	$32.8MSEC filing	+378.0%from $6.9M
Mar 31, 2026Reported May 13, 2026	-$0.58est. -$0.55	-5.94%miss	$20.8MSEC filing	+57.5%from $13.2M
Dec 31, 2025Reported Mar 9, 2026	-$0.22est. -$0.02	-$0.20miss	$41.2MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	$0.27est. -$0.51	+$0.78beat	$72.8MSEC filing	-34.2%from $110.7M
Jun 30, 2025Reported Aug 14, 2025	-$0.57est. $0.38	-$0.95miss	$6.9MSEC filing	-36.4%from $10.8M
Mar 31, 2025Reported May 13, 2025	-$0.65est. -$0.69	+5.80%beat	$13.2MSEC filing	+44.9%from $9.1M
Dec 31, 2024Reported Mar 20, 2025	-$0.82est. -$0.59	-38.64%miss	$150.0M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 5, 2024	$0.90est. $0.60	+50.00%beat	$110.7MSEC filing	+964.8%from $10.4M

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $2.37
52-wk high: $5.08
High: $2.44
52-wk low: $1.29
Low: $2.24
Prev close: $2.38
Mkt cap: $152.9M
ROE: -225.9%
Fwd P/E: 61.0x
Beta: 1.21
P/S: 0.9x
P/B: 3.5x
Profit margin: -8.3%
Op margin: -42.2%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -8.3%
Forward P/E: 60.98
Market cap: $153M

Valuation

P/S0.87
P/B3.53

Quality

Operating margin-42.2%
ROE-225.9%
ROA-8.1%

Growth

Beta1.21

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

26oversold

20D volatility

184%annualized

52-week range

$2.40

$1.29$5.08

20D support

$1.93recent floor

20D resistance

$3.85recent ceiling

Returns

5D +6.7%20D -33.0%60D -40.1%

Price vs moving averages

SMA20 -24.4%SMA50 -34.9%SMA200 -29.8%

Volume pace

1.65xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Jun 30, 2026Aug 13, 2026

$1.14est. $0.26

+$0.88

$32.8MSEC filing

+378.0%from $6.9M

Mar 31, 2026May 13, 2026

-$0.58est. -$0.55

-5.94%

$20.8MSEC filing

+57.5%from $13.2M

Dec 31, 2025Mar 9, 2026

-$0.22est. -$0.02

-$0.20

$41.2MYahoo Finance

No year-ago quarter

Sep 30, 2025Nov 12, 2025

$0.27est. -$0.51

+$0.78

$72.8MSEC filing

-34.2%from $110.7M

Jun 30, 2025Aug 14, 2025

-$0.57est. $0.38

-$0.95

$6.9MSEC filing

-36.4%from $10.8M

Mar 31, 2025May 13, 2025

-$0.65est. -$0.69

+5.80%

$13.2MSEC filing

+44.9%from $9.1M

Dec 31, 2024Mar 20, 2025

-$0.82est. -$0.59

-38.64%

$150.0M · FYSEC filing

No year-ago quarter

Sep 30, 2024Nov 5, 2024

$0.90est. $0.60

+50.00%

$110.7MSEC filing

+964.8%from $10.4M

MacroGenics Inc

Smart money at a glance

What do analysts expect?

Questions about MGNX filings

Smart money on MGNX

Questions about MGNX filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in $0.88 a share above what analysts expected.

Estimated report: Nov 11, 2026, in 11 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

MacroGenics Inc

Smart money at a glance

What do analysts expect?

Questions about MGNX filings

Smart money on MGNX

Questions about MGNX filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in $0.88 a share above what analysts expected.

Estimated report: Nov 11, 2026, in 11 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

MacroGenics Inc

Overview

Questions about MGNX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

MacroGenics Inc

Overview

Questions about MGNX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.